Pontificia Universidad Catolica de Chile
uc.clTotal trials
208
Active
39
Phase 3
9
Total enrollment
123,933
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 12 of 12 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Lidocaine | — | — | — | — | 3 | ||
| Colchicine | — | — | — | — | — | 1 | |
| Surgical implantation with standard (DRM) or photosynthetic dermal regeneration matrices (PDRM) in same patient. | — | — | — | — | — | 1 | |
| Propofol | — | — | — | — | 5 | ||
| Sedative | — | — | — | — | — | 1 | |
| Hemodynamic monitor, BIS, TOF, ANI, anesthesia machine and infusion pumps | — | — | — | — | — | 1 | |
| Intraoperative | — | — | — | — | — | 1 | |
| Post-operative | — | — | — | — | — | 1 | |
| Infliximab | — | — | — | — | — | 1 | |
| administration of dexamethasone intravenously | — | — | — | — | — | 1 | |
| Tuberculosis window prophylaxis with weekly rifapentine and isoniazid for 12 weeks | — | — | — | — | — | 1 | |
| Standard of care tuberculosis prophylaxis with weekly rifapentine and isoniazid for 12 weeks | — | — | — | — | — | 1 |
Next readouts
- 2024-12-31
- 2025-07-01
- 2026-01
- 2026-03-30
- 2026-07-01
- 2026-10-27
- 2026-12-01
- 2026-12-01
- 2028-05
- 2028-05
Top conditions
- Anesthesia13
- Covid197
- Pain7
- Septic Shock6
- Obesity6
- Breast Cancer6
- Critical Illness5
- Hypertension4
Frequently asked questions about Pontificia Universidad Catolica de Chile
- How many clinical trials does Pontificia Universidad Catolica de Chile have on ClinicalTrials.gov?
- Pontificia Universidad Catolica de Chile is listed as the lead sponsor on 208 clinical trials in ClinicalTrials.gov, 39 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Pontificia Universidad Catolica de Chile's trials are in Phase 3?
- 9 of Pontificia Universidad Catolica de Chile's trials are in Phase 3, spread across 12 active drug programs.
- What therapeutic areas does Pontificia Universidad Catolica de Chile focus on?
- Pontificia Universidad Catolica de Chile's most-studied conditions on ClinicalTrials.gov are Anesthesia, Covid19, Pain, Septic Shock, Obesity.
- When are Pontificia Universidad Catolica de Chile's next clinical trial readouts?
- Pontificia Universidad Catolica de Chile has 10 upcoming primary-completion readouts tracked here; the soonest is “Methadone Pharmacokinetics in End-stage Renal Disease”, expected around 2024-12-31.